AGP Executive Report

Swiss Justice: In the Winterthur stabbing case, Switzerland’s Office of the Attorney General says it still can’t access the suspect’s laptop and mobile phone because he objects to the search, so prosecutors can’t yet map who he contacted or what was written. Obesity Drug Watch: At the American Diabetes Association meeting, Roche and Zealand highlighted tolerability for their amylin-based obesity drug petrelintide, reporting mostly mild gastrointestinal side effects and a reported 22.7% average weight loss in a mid-stage trial. Ebola Update: The WHO reports the central Africa Ebola outbreak is nearing 500 confirmed cases, with concern growing that it could become one of the largest on record without strong public health action. Sports & Health: Lionel Messi sat out Argentina’s pre-World Cup friendly with hamstring muscle fatigue/strain, while Switzerland’s Granit Xhaka spoke about leading the team at the 2026 tournament. Public Health & Care: Switzerland is taking steps to improve support for women with endometriosis, aiming to strengthen care pathways. Health Research (Switzerland): A Zurich study suggests Swiss recruits’ sperm quality is holding steady.

Ebola Watch: WHO reports nearly 500 confirmed Ebola cases in central Africa, with 452 cases and 82 deaths in the Democratic Republic of Congo and 19 cases in Uganda, as the outbreak grows and WHO warns it could become the largest on record without strong interventions. Swiss Healthcare Policy: The Swiss government approved a report calling for earlier diagnosis and better treatment of endometriosis, noting many women wait years for care and that current system gaps worsen pain, fatigue, anxiety and fertility challenges. Regulator vs Media: Neue Zürcher Zeitung (NZZ) is fighting Swissmedic in court after the regulator ordered deletions of articles it said were unauthorized advertising for prescription-only medicines, including weight-loss drug coverage. Sports & Health (Switzerland link): Tiger Woods is reportedly continuing rehab in Switzerland through the end of June while supporting girlfriend Vanessa Trump after her breast cancer diagnosis. Public Health & Safety: A Swiss-led project is highlighted for a potential treatment target in age-related macular degeneration, pointing to new avenues for eye health.

Swissmedic vs media: Neue Zürcher Zeitung (NZZ) is fighting Swissmedic in court after the regulator ordered deletions of articles it said were unauthorised advertising for prescription-only medicines, including a migraines piece and several weight-loss drug reports. Obesity drug race: Roche said its experimental dual-acting obesity drug enicepatide helped mid-stage patients lose 22.7% of body weight after 48 weeks, with no plateau signal at that point. Cannabis and hormones: A University of Geneva study in Swiss conscripts found regular cannabis use did not lower testosterone in young men and may even raise it, alongside proposed new hormonal markers of use. Assisted dying debate: A new discussion weighs assisted dying “for and against,” highlighting comfort for some patients, but also travel-related inequity and legal risks for helpers. Digital sovereignty: Swissinfo looks at whether Switzerland can truly distance daily life from Big Tech, after two journalists tried cutting ties with US tech giants. Dental health: Dentists warn that frequent seltzer sipping can erode enamel, especially when it’s consumed throughout the day rather than with meals. Swiss research spotlight: Zurich researchers report oxytocin rises during group competition, especially when rivals are familiar, with stronger effects noted in men.

Obesity Drug Update (Swiss-linked): Zealand Pharma says its experimental once-weekly obesity injection petrelintide (co-developed with Swiss partner Roche) was generally well tolerated in a mid-stage trial, with GI side effects mostly mild and some improvements in cardiovascular risk markers. Public Health & Preparedness (Ebola): EU health ministers coordinated on the Ebola Bundibugyo Virus outbreak in Central Africa, with Switzerland joining discussions alongside ECDC and WHO on cross-border readiness. Mental Health & Daily Life: A study from the University of Zurich suggests long-term close contact with the same work colleagues can worsen loneliness, conflict, and paranoia—relevant for people working in tight teams or remote hubs. Child Health: A BMJ analysis warns progress in newborn and child survival has slowed, with many countries unlikely to meet 2030 targets. Swiss Care & Research (Biotech): Memo Therapeutics shared further Phase II analyses of potravitug for BK virus in kidney transplant patients, reporting consistent viral load reductions. Swiss Society & Safety: Lawyers are set to question bar owners again in the Crans-Montana New Year fire case that killed 41. Nutrition & Longevity: Dietitians highlight foods—especially fruits, vegetables, and legumes—as key supports for longer, healthier aging.

Swiss Health Policy: Ticino voters will decide on 14 June whether to introduce Switzerland’s first compulsory cantonal dental insurance, aiming to make basic dental care part of public health and funded by employees, employers and the canton (opponents warn of about CHF 150m a year in costs). Reproductive Health: A University of Zurich study finds sperm quality among young Swiss men is broadly stable, with only 41% below WHO guidelines on at least one measure (down from 62% in an earlier sample), while recent Covid-19 infection is linked to lower counts but the effect seems to fade. Medical Innovation: Swiss researchers report microrobots that could repair spinal cord damage by stimulating stem cells with externally applied magnetic fields, with the robots designed to dissolve after treatment. Cyber & Safety for Health Systems: Papers AG launched “Obsidio,” a Swiss tool for realistic DDoS resilience testing using a large smartphone-based setup, targeting documentation needs for Swiss and European regulators. Public Health & Environment: On World Environment Day, IPEN urges global controls on lead chromates under the Rotterdam Convention, citing lead paint as a major source of child lead exposure. Population Debate: A June 14 Swiss vote proposes capping the permanent resident population at 10 million by 2050, with UBS CEO Sergio Ermotti calling it an “extreme” measure that won’t solve underlying pressures.

Swiss Health Policy & Housing: Swiss voters are set to decide on June 14 whether to cap the population at 10 million, a move backed by the Swiss People’s Party that could reshape immigration rules and EU freedom-of-movement arrangements amid housing, transport, and public-service strain. Pharma & Trade: Roche chairman Severin Schwan says US tariff threats over medicines amount to “blackmail,” warning that protectionism from both the US and China is the firm’s biggest geopolitical risk. Public Health Collaboration: WHO and China are stepping up health cooperation in Cabo Verde, aligning on new areas for joint work. Research Capacity: FHNW in Northwestern Switzerland has opened an HPC Lab to support next-gen AI and scientific computing, including applications relevant to medicine and health research. Noncommunicable Disease Focus: Moldova hosts an international NCD conference (June 3–5) with Swiss participation, covering prevention, nutrition, tobacco control, and cross-sector health promotion. Food & Nutrition Industry: Nestlé buys the remaining stake in yfood, a ready-to-drink meal brand, signaling continued momentum in convenient nutrition.

Swiss Health Policy & Pharma: Swissinfo reports regulators are probing whether obesity awareness campaigns by pharma firms (including Eli Lilly) breach rules on advertising prescription-only medicines to the public, with Swissmedic launching an investigation and France fining companies for indirect promotion. Reproductive Health: A University of Zurich and Zurich University Hospital study finds sperm quality in Swiss army recruits has stayed stable since 2005–2017, with 2021 data showing fewer men below WHO sperm-count standards than earlier cohorts. Men’s Health & Substance Use: A University of Geneva study links cannabis use in young Swiss men to about 23% higher testosterone, while stressing the fertility impact remains unclear. Dermatology & Beauty Industry: Incanthera PLC acquired Swiss skincare brand Énielle in an all-share deal and named a new CEO, sending shares up 21%. Healthcare Business: Mediclinic reported revenue and earnings growth while navigating restructuring, including large non-cash impairment charges tied to Switzerland assets. Legal/Health-Adjacent Court Case: A court in Nyon heard allegations that Australian racing driver Joey Mawson sexually assaulted a nurse at Michael Schumacher’s Swiss mansion; Mawson denies wrongdoing. Public Health & Safety: Swiss microbots are reported as repairing spinal cords with stem cells, pointing to new directions in regenerative care.

Climate & Heat Risk: The UN’s weather agency warns El Niño could be moderate to strong, raising temperatures and the odds of extreme weather, including heatwaves, heavier rain and drought in different regions. Digital Health & Child Safety: Meghan Markle renewed her push for protecting children in digital spaces, even as critics questioned the timing after she shared new family photos from Geneva. Pharma & Access: Lilly and Boehringer plan to cut major investment in Germany after a new healthcare reform aims to curb costs and trigger deeper discounts on branded medicines—an issue Swiss pharma leaders have also criticized. Swiss Health Innovation: EPFL researchers report a breakthrough miniaturized ultrafast laser on a photonic chip, a step toward faster medical and scientific tools. Burn Care in Switzerland: A new Swiss-Belgian association, Initiative Phoenix, is forming to support burn victims and coordinate burn-care innovation after the Crans-Montana bar fire. Mental Health & Policy Debate: UK polling finds broad support for psilocybin-assisted therapy across political parties, fueling calls to move it out of Schedule 1. Cross-border Care: A dental clinic in Albania reports rising demand from Western and Central Europe as patients seek shorter waits and lower costs.

Medical safety in focus: Zurich’s University Hospital scandal is widening after a commission linked 70+ unexpected cardiac surgery deaths (2016–2020) to possible inappropriate use of implantable devices, including the Cardioband, prompting a criminal investigation. Mental health & AI: A new AXA/IPSOS survey finds 68% of people seek mental health advice via AI, but 45% are dissatisfied—especially among 18–24s. Research & innovation: ETH Zurich researchers report magnetically guided “NPCbots” (neural progenitor cell biohybrid robots) that repaired spinal cord injuries in zebrafish larvae within days. Neurotech company update: MindMaze Therapeutics announced its 2026 AGM in Geneva (June 25) and board proposals. Policy & society: Swiss voters appear set to reject a referendum capping population at 10 million by 2050, with concerns about housing, transport, and hospitals driving support. Healthcare industry: Amcor is expanding healthcare packaging capacity in Sira, Karnataka, adding automated quality systems and new jobs. Cybersecurity: Anthropic is expanding Claude Mythos access to partners in Switzerland and other countries via Project Glasswing.

Swiss security & mental health: Swiss train-station stabbing suspect Nesip Dedeler, linked to ISIS propaganda, was released from psychiatric care days before the Winterthur attack, raising questions about how risk is assessed after hospital stays. Cancer drug watch (Switzerland-linked pharma): Roche is regrouping after a first-line breast cancer setback for oral SERD giredestrant, pointing to new plans testing the drug in earlier-stage settings. Digital health & fairness: Research on AI “digital twins” for heart disease warns that models may miss key biological differences between women and men, risking less personalised care. Work & rights in Geneva: Platform workers in Kenya are pushing for a new international convention on decent work in the platform economy, with talks expected during the ILC in Geneva. Geneva airport retail: Lagardère Travel Retail renewed duty-free and fashion concessions at Geneva Airport, with a refreshed concept and Relay brand debut. Health system travel ethics (Philippines, Geneva WHA): A report says a health undersecretary’s World Health Assembly travel was upgraded to business class, sparking scrutiny over perks.

Geneva as Brain Health Hub: The European Academy of Neurology’s 12th Annual Congress (27–30 June 2026) will draw about 7,000 specialists to Palexpo, with Geneva named “European Capital of Brain Health” and backed by public talks, school outreach, and a wider awareness campaign. Newborn Meningitis Prevention: ETH Zurich and the University of Basel report a strategy to block transmission of E. coli K1 from mother to premature babies, aiming to reduce life-threatening newborn meningitis without relying on antibiotics. Eye Health Screening: A free school eye screening in Ghana—run with a Swiss-based NGO—found only 98 of 1,123 children had normal vision, highlighting the need for early diagnosis and treatment. Duchenne Drug Access Push: Santhera says South Korea has granted orphan drug and fast-track priority review designations for AGAMREE (vamorolone) for Duchenne muscular dystrophy, with an application planned for 2026. Workplace Wellbeing Research: A University of Zurich-led study from Antarctica suggests that in small teams under extreme isolation, more frequent contact can increase conflict and mistrust and reduce perceived performance.

Ebola Recovery: Four nurses treated for Ebola (Bundibugyo virus) in Bunia, Ituri, have been discharged after recovering, with more recoveries expected as early diagnosis and access to care improve. Swiss Health Policy Vote: Switzerland is set to vote on a right-wing “No to ten million” initiative that would cap the population by 2050 and tighten immigration rules, potentially including ending EU free movement as a last resort—fueling fears of a “Swiss Brexit.” Cardiovascular Drug Update (Switzerland-linked): Idorsia reported Phase 3 PRECISION results for aprocitentan in resistant hypertension with albuminuria, showing rapid reductions in urine albumin-creatinine ratio and a manageable safety profile. Newborn Infection Prevention: A new treatment aims to prevent meningitis in newborns without antibiotics, targeting a major cause of early-life illness. Genomics & Proteomics Tools: INTEGRA Biosciences and Evosep announced workflow-focused advances to make genomics and LC-MS proteomics more standardized and scalable—aimed at improving reproducibility for research and drug development. Public Health Research: A study suggests mosquitoes can learn to associate DEET with a blood meal, reinforcing the need for correct and repeated repellent use.

Swiss Health Policy & Access: A Zurich roundtable on mental health and disability insurance focused on reforming product design, with stakeholders warning that current disability cover can fail people with mental health conditions. Tobacco Control (WHO): The WHO’s European office picked Spain to host its 2026 conference on a healthier, tobacco-free future in Europe, with awards during World No Tobacco Day. Diabetes Care (Switzerland-based company): Ascensia Diabetes Care (Basel) launched CONTOUR®COMFORT pen needles, aiming to improve stability and comfort for everyday insulin injections. Hypertension & Kidney Risk (Idorsia): New analyses from Idorsia’s PRECISION study suggest aprocitentan can reduce albuminuria and improve kidney-risk categories in resistant hypertension. Public Health Funding (ring-fencing): Zimbabwe’s move to ring-fence sugar and fast-food tax revenue for health programmes highlights a policy model that could interest Swiss health planners. Heat & Safety: Europe’s early heatwave, including extreme temperatures expected in Switzerland, is raising public health and civil protection concerns. Waste & Health Costs (Switzerland link): An IFC report says digital waste systems can cut health and environmental costs; it cites Swiss sorting plants reaching up to 95% recovery using AI and optical sensors.

Ebola Watch: Africa CDC confirms a new Ebola outbreak in Congo’s Ituri province, with 246 suspected cases and 65 deaths reported so far, plus a confirmed case in Uganda after a posthumous test—raising concern over cross-border spread amid conflict and contact-tracing gaps. Swiss Health Innovation: Novartis reports early signs of anti-tumour activity from an experimental actinium-based radioligand drug in prostate cancer, including PSA drops in patients previously treated with Pluvicto, while analysts flag side effects like dry mouth and severe anaemia as a key next hurdle. Public Health Access: A free eye screening in Ghana (run with a Swiss-based NGO) found only 98 of 1,123 children had normal vision, with most needing medication or glasses—highlighting the need for early detection and treatment. Wellbeing & Safety: Switzerland’s train-station knife attack in Winterthur is repeatedly described by authorities as terrorism, with multiple reports of injuries and ongoing investigation. Climate & Health Risk: A record-breaking May heatwave in Portugal is part of a wider European pattern, with Switzerland among countries bracing for extreme temperatures—pushing public health and civil protection into high alert. STEM & Health Education: A Caribbean–Swiss space biology mission launched from Esrange, aiming to strengthen STEM education and research capacity in St. Kitts and Nevis with University of Zurich involvement.

Cancer Care & Trials: BioNTech and Bristol Myers Squibb shared interim Phase 2/3 ROSETTA Lung-02 results for pumitamig (PD-L1xVEGF-A) plus chemotherapy in first-line advanced non-small cell lung cancer, reporting strong response rates across PD-L1 levels and subtypes, with Phase 3 enrollment ongoing. Public Health & Youth Vision: A Swiss-backed eye screening in Ghana found only 98 of 1,123 children had normal eyesight, with most needing treatment or glasses—highlighting the impact of early detection. Cannabis & Hormones: A Swiss study measuring 70 steroid hormones in young men suggests cannabis effects on testosterone are more complex than “just lower testosterone,” with some hormone levels higher while other pathways stay similar. Mental Health & Security: Swiss newspapers report debate after the Winterthur train-station knife attack, focusing on how clinicians assess psychological instability versus radicalisation risk. Health Tech & Delivery: Matternet raised about $33M and completed a go-public reverse merger to expand autonomous drone delivery, including healthcare use cases. Wellness & Climate Resilience: Zurich’s long-running green-roof push is spotlighted as a practical way to cool cities as warming accelerates.

Swiss health policy & costs: Switzerland’s health office says premiums are set to rise next year, adding pressure for households already juggling higher living costs. Cancer screening gap: A nationwide Swiss study reports colorectal cancer is increasingly showing up in people under 50, often at later stages—highlighting the need for earlier symptom awareness. Infectious disease & climate: A Lancet Planetary Health study links climate change to rising antibiotic resistance in Salmonella, with Swiss researchers among the teams analyzing hundreds of thousands of samples. Mental health & safety in the news: Swiss authorities are treating a Winterthur train-station stabbing as an act of terrorism, with three people wounded and a psychiatric ward probe launched. Innovation in care: GE HealthCare submitted MIM KineticID for FDA review, aiming to expand dynamic PET imaging and more quantitative analysis for clinicians and researchers.